. Scheme adopted to differentially label promoter DNA at nucleobase position 5-in deoxycytidine. The approach taken to compare the bisulfite treatment of differentially labeled DNA amplicons is depicted. PCR products were generated using human or mouse promoter derived sequences by incorporating (a) dCTP, (b) dmCTP (5-methylcytidine), or (c) dhmCTP (5-hydroxy-methylcytidine) with dATP, dGTP, and dTTP. Products were purified and analyzed by methyl-sensitive restriction enzyme digestion or bisulfite sequencing. Figure S2 . Map of enzymatic recognition sites in BRCA1 and CDH1 regions analyzed using methylcytosine-sensitive restriction enzymes. NEBCutter (http://tools.neb.com/NEBcutter2) was used to depict the arrangement of the restriction endonucleases tested (HpaII/MspI, HpyCH4IV, HhaI, HaeIII, and PstI).
Templates used for PCR BRCA1 containing a CpG island, the BRCA1 5′-UTR, exon 1, and a portion of intron 1 (-245 to +909) was amplified from BRCA1 promoter cloned into pGEM-T Easy vector. CDH1 was amplified using a region of CDH1 containing a CpG island, the CDH1 promoter, exon 1, and exon 2 (-409 to +1263), cloned into pGEM-T Easy vector. Hemi-hydroxymethylated CDH1 DNA was generated by subjecting purified hydroxymethylated CDH1 to one round of PCR amplification in the presence of unmodified dNTPs. Oct4 was amplified using a region of mouse Oct4 exon 1 (+178 to +276) cloned into pGEM-T Easy vector. Tex19.1 was amplified using a cloned region of mouse Tex19.1 derived from unrelated bisulfite sequencing experiments. The utility of this template is that a 270-bp stretch of the Tex19.1 promoter is modified in such a way that all cytidine bases are in the context of CpG dinucleotides (-287 to -17) . PCR amplification was carried out using Taq DNA polymerase (Invitrogen, Paisley, UK) with dCTP-dNTPs, dmCTPdNTPs or dhmCTP-dNTPs (each dNTP is at 2mM) -cycling details available on request -dmCTP (Fermentas, York, UK) and dhmCTP (BioLine, London, UK).
Digestion of differentially labeled PCR amplicons BRCA1 and CDH1 PCR amplicons (see "Templates used for PCR" section) were gel purified (Machery-Nagel GmbH, Düren, Germany) and resuspended at 100 ng/ µL in TE buffer pH 8 (10 mM Tris pH 8, 1 mM EDTA). Products were digested with 2-200 U of the following restriction enzmyes: HpaII, HaeIII, HhaI, MspI, PstI, (all, Roche Diagnostics, Burgess Hill, UK) or HpyCh4IV (New England BioLabs, Hitchin, UK). Finally, digestion products were resolved using 1.5% TBE (Tris/Borate/ EDTA, Sigma-Aldrich, Poole, UK) agarose gel electrophoresis, post-stained with 50 μg/mL ethidium bromide and phosphorimaged (Fujifilm FLA-5100, Fuji Storm, Bedford, UK).
Bisulfite sequencing of differentially labeled PCR amplicons Gel-purified PCR products from Oct4 and Tex19.1 generated in the "Templates for PCR" section were used as inputs in bisulfite conversion experiments (EZ DNA Methylation Kit, Zymo Research, Orange, CA, USA) with minor modifications. Products (100-250 ng) were incubated with CT conversion reagent according to manufacturer's instructions except incubating at 53°C for 2.5 h instead of 68°C [which caused severe strand breakage due to depurination and thereby hampered subsequent cloning (data not shown)]. Oct4-treated PCR products were tailed using 0.2 mM dATP and 0.2 U Taq DNA polymerase at 72°C for 5 min, gel-purified, and cloned directly in 
Oct4-OR1-BisProt CTAGGCCCAGTCCAACCTG

Oct4-OF-BisUnprot TTAGGTTTAGAGGTATTG
Oct4-OR1-BisUnprot
Benchmarks pGEM-T Easy (Promega, Southampton, UK). Tex19.1 bisulfite-treated products were amplified by PCR for 6-8 cycles (dATP tailing was insufficient for direct cloning of this fragment), gel-purified, and cloned into pGEM-T Easy using the Rapid ligation system (Roche). Ligation products were transformed into Dh5α supercompetent cells, plated on LB agar plates supplemented with 50 μg/mL ampicillin (Sigma-Aldrich) and 20 mg/mL X-gal (5-bromo-4-chloro-3-indolyl-β-D galactopyranoside; Sigma-Aldrich). Miniprep plasmid DNA was isolated using the Nucleospin Miniprep system (MacheryNagel GmbH) and was sequenced with T7 and SP6 primers using the BigDye Terminator v3.1 sequencing platform (Applied Biosystems, Warrington, UK).
DNA dot blotting
Gel-purified PCR products from Oct4 were quantitated spectrophotometrically followed by immobilization onto nitrocellulose in 0.4 M NaOH using a dot blot apparatus under vacuum. Samples were adhered to the membrane at 80°C under vacuum followed by probing with an anti-5mC monoclonal antibody (Eurogentec, Southampton, UK) at concentrations of 0.1-1 μg/mL in TBS and Western Block reagent (Roche). Membranes were probed with anti-HRP antibodies prior to development under Kodak film (Kodak, Hemel Hempstead, UK). To control for DNA loading, duplicate dot blots were probed with a rabbit polyclonal raised against single-stranded DNA (Demeditec Diagnostics, Kiel-Wellsee, Germany).
Supplementary Figure S4 . Non-CpG hydroxymethylation of CDH1 inhibits digestion by PstI. Shown is a representative PstI digest of differentially cytidine labeled human CDH1 CpG island amplicons. Unmethylated CDH1 is efficiently cleaved by PstI compared with the mock digested amplicons (compare dCTP lanes). Hydroxymethylated CDH1 is resistant to PstI cleavage at up to a 60-fold excess of enzyme (see hmdCTP lanes). Finally, hemi-hydroxymethylated CDH1 is also resistant to PstI digestion (hemi-dhmCTP lane).
Supplementary Figure S5 . α-5mC monoclonal antibody shows a preference for methylated Oct4 over hydroxymethylated Oct4 at high antibody concentrations. A representative DNA dotblot probed with 1 μg/mL α-5mC monoclonal antibody (Eurogentec) is shown. Oct4 PCR products were generated as described in Supplementary Figure S1 and immobilised on nitrocellulose. Note the higher 5mC signal in dmCTP-Oct4 compared with dhmCTP-Oct4, a ratio which increases at lower DNA concentrations (see densitometry on right). Unmodified cytosine in dCTP-Oct4 DNA shows low background levels of antibody affinity. 5mC signals are undetectable in unmodified plasmid DNA (set as background). Note that antibody concentrations in the manuscript are 0.1 μg/mL.
